Dr. Sartori and High PH Therapy Cesium Chloride A Therapy For Cancer

XYZ-Wellbeing ReTreat Facility are the only people who have experience in this IV Therapy. It is wrong and can be dangerous to do this therapy with-out a skilled person assisting you. These above specialists have the benefits of my many 40 years experience in the field of Cancer and specializing with what I believe is the best, High PH therapy.

DrPablo at a new clinic opening early in 2009 www.XYZ-Wellbeing.com Dr Pablo heads up the team in a new six year Cancer Trial On Alternative Treatments in Combination. They run for the FIRST 21 DAYS of each month commencing with a weekend workshop the first Saturday of each month. This is a holistic combination that will give you the best possible outcome using these therapies.

» Read more: Dr. Sartori and High PH Therapy Cesium Chloride A Therapy For Cancer

Related posts

BioSante plans new prostate cancer drug testing

BioSante plans new prostate cancer drug testing
BioSante Pharmaceuticals Inc. said Monday it hopes to restart testing of an experimental prostate cancer drug almost two years after the research was stopped.

Read more on AP via Yahoo! Finance

Related posts

New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.

“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.

» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Related posts